Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Front Microbiol. 2013 Mar 14;4:48. doi: 10.3389/fmicb.2013.00048. eCollection 2013.

"Stormy waters ahead": global emergence of carbapenemases.

Author information

  • 1Department of Medicine, Mount Sinai School of Medicine New York, NY, USA.

Abstract

Carbapenems, once considered the last line of defense against of serious infections with Enterobacteriaceae, are threatened with extinction. The increasing isolation of carbapenem-resistant Gram-negative pathogens is forcing practitioners to rely on uncertain alternatives. As little as 5 years ago, reports of carbapenem resistance in Enterobacteriaceae, common causes of both community and healthcare-associated infections, were sporadic and primarily limited to case reports, tertiary care centers, intensive care units, and outbreak settings. Carbapenem resistance mediated by β-lactamases, or carbapenemases, has become widespread and with the paucity of reliable antimicrobials available or in development, international focus has shifted to early detection and infection control. However, as reports of Klebsiella pneumoniae carbapenemases, New Delhi metallo-β-lactamase-1, and more recently OXA-48 (oxacillinase-48) become more common and with the conveniences of travel, the assumption that infections with highly resistant Gram-negative pathogens are limited to the infirmed and the heavily antibiotic and healthcare exposed are quickly being dispelled. Herein, we provide a status report describing the increasing challenges clinicians are facing and forecast the "stormy waters" ahead.

KEYWORDS:

CHDL; KPC; NDM-1; OXA-48; carbapenemases; metallo-β-lactamases

PMID:
23504089
[PubMed]
PMCID:
PMC3596785
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Frontiers Media SA Icon for PubMed Central
    Loading ...
    Write to the Help Desk